Helen Moore

1.7k citations
61 papers · 1.1k indexed · h-index 18
Topics
Chronic Lymphocytic Leukemia Research (6 papers)Chronic Myeloid Leukemia Treatments (6 papers)Cancer Genomics and Diagnostics (4 papers)

In The Last Decade

Helen Moore

58 papers receiving 1.1k citations

Peers

Helen Moore
Comparison fields: 5 of 138
  • Molecular Biology 303
  • Public Health, Environmental and Occupational Health 208
  • Hematology 199
  • Immunology 173
  • Modeling and Simulation 151
Replace Hannah Chang with:
Hannah Chang United States
Corrie Painter United States
Mary E. Sehl United States
Reid F. Thompson United States
Amanda Jackson United States
Kewei Ma China
Qiushi Lin United States
Elena Soto‐Vega Mexico
Jing Liao China
T. Rytömaa Finland
Helen Moore relative to Hannah Chang United States Hannah Chang's profile →
Citations per field
00.5×3.7×
Hannah Chang · 1×
Citations per year

Countries citing papers authored by Helen Moore

Since Specialization
Citations

This map shows the geographic impact of Helen Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Moore more than expected).

Fields of papers citing papers by Helen Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Moore. The network helps show where Helen Moore may publish in the future.

Co-authorship network of co-authors of Helen Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Moore. A scholar is included among the top collaborators of Helen Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Moore. Helen Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 0
4 7
5 1
6 34
7 14
8 11
9 82
10 7
11 15
12 42
13 1
14 87
15 71
16 87
17 42
18 7
19 30
20 3

About Helen Moore

Helen Moore is a scholar working on Hematology, Internal Medicine and Genetics, having authored 61 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Modeling and Simulation (151 citations), Hematology (199 citations) and Aging (27 citations). Helen Moore has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include David Whitmore, Suzanne Lenhart, Khalid Tobal, Heddy Zola, Mamta Garg, John A. Liu Yin, Jim Vaught, Nicole C. Lockhart, Urszula Ledzewicz and Carolyn C. Compton. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026